Delivery Order SPE2DR25D9329-SPE2DR26FJVF4
Award Date 4/24/26
Potential Completion Date 5/15/26
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, for $11,771.46 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Nuplazid 34 mg capsules. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, SPE2DR, is a single-award indefinite delivery contract with a $499.9 million ceiling and ultimate completion date of December 31, 2036, supporting pharmaceutical supply to...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 6, 2026, for $11,771.46 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Nuplazid 34 mg capsules (30-count). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, for Nuplazid 34 mg capsule 30-count units with a ceiling value of $11,771.46 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the single-award indefinite delivery contract SPE2DX, a $499.999 billion vehicle awarded by the Defense Logistics Agency on November 13, 2025,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 13, 2026, for $11,771.46 to supply Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, for Nuplazid 34 mg capsule 30s with a ceiling value of $3,923.82 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical and medical consumable supply to Department of Defense military...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 13, 2026, for supply of Nuplazid 34 mg capsules, with a ceiling value of $11,771.46. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a $11,771.46 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, for Nuplazid 34 mg capsule 30-count units under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical...
- The Defense Logistics Agency issued a $11,771.46 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is placed against the company's single-award IDC under PPV-G GEN V, a $499.999 billion Defense Logistics Agency pharmaceutical supply contract with a completion date of December 31, 2036. The PPV-G GEN V...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, for Nuplazid 34 mg capsule supply, with a ceiling value of $11,771.46, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. The order carries a firm fixed price and an ultimate completion date of April 29, 2026. This delivery order is issued against the...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the PPV-G GEN V, a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of...